Supplementary Table III.
PCOS Group | OD Group | |||||
---|---|---|---|---|---|---|
Canonical Pathways | p-value | Overlap | p-value | Overlap | ||
LXR/RXR Activation | 9,04E-11 | 7.0% | 9/128 | |||
FXR/RXR Activation | 1,67E-10 | 6.6% | 9/137 | |||
Extrinsic Prothrombin Activation Pathway | 1,70E-07 | 22.2% | 4/18 | |||
Acute Phase Response Signaling | 5,21E-07 | 4.1% | 7/171 | 3,06E-03 | 2.9% | 5/171 |
Intrinsic Prothrombin Activation Pathway | 1,48E-06 | 13.3% | 4/30 | |||
Allograft Rejection Signaling | 1,29E-02 | 3.5% | 3/85 | |||
Communication between Innate and Adaptive Immune Cells | 1,50E-02 | 3.3% | 3/90 | |||
Crosstalk between Dendritic Cells and Natural Killer Cells | 1,50E-02 | 3.3% | 3/90 | |||
Germ Cell-Sertoli Cell Junction Signaling | 1,86E-02 | 2.3% | 4/176 |